Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Arista Networks
ANET
|
$246M |
| 2 |
Lam Research
LRCX
|
$236M |
| 3 |
Spotify
SPOT
|
$189M |
| 4 |
Palo Alto Networks
PANW
|
$160M |
| 5 |
Tractor Supply
TSCO
|
$63.9M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$500M |
| 2 |
Microsoft
MSFT
|
$426M |
| 3 |
Amazon
AMZN
|
$245M |
| 4 |
Meta Platforms (Facebook)
META
|
$194M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$167M |
Sector Composition
| 1 | Technology | 33.9% |
| 2 | Consumer Discretionary | 12.65% |
| 3 | Healthcare | 10.7% |
| 4 | Communication Services | 9.68% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Hagerty
HGTY
$1.14B
| $511K | ﹤0.01% | 53,000 +3,000 | +6% | +$29K |
|
2402
Mercer International
MERC
$223M
| $511K | ﹤0.01% | 78,672 | – | – |
|
2403
Donegal Group Class A
DGICA
$653M
| $504K | ﹤0.01% | 32,600 | – | – |
|
2404
SIGA Technologies
SIGA
$601M
| $504K | ﹤0.01% | 83,900 | – | – |
|
2405
Oric Pharmaceuticals
ORIC
$994M
| $504K | ﹤0.01% | 62,400 +3,200 | +5% | +$25.8K |
|
2406
Pharvaris
PHVS
$1.39B
| $503K | ﹤0.01% | 26,257 | – | – |
|
|
SAGE
2407
DELISTED
Sage Therapeutics
SAGE
| $481K | ﹤0.01% | 88,600 | – | – |
|
2408
Bristow Group
VTOL
$1.11B
| $477K | ﹤0.01% | 13,900 | – | – |
|
2409
Y-mAbs Therapeutics
YMAB
$388M
| $472K | ﹤0.01% | 60,300 | – | – |
|
2410
Gray Television
GTN
$626M
| $472K | ﹤0.01% | 149,702 -17,798 | -11% | -$56.1K |
|
2411
Westrock Coffee
WEST
$512M
| $449K | ﹤0.01% | 69,900 | – | – |
|
2412
Olaplex Holdings
OLPX
$954M
| $447K | ﹤0.01% | 258,100 | – | – |
|
2413
1-800-Flowers.com
FLWS
$356M
| $444K | ﹤0.01% | 54,400 | – | – |
|
2414
KRONOS Worldwide
KRO
$734M
| $443K | ﹤0.01% | 45,400 | – | – |
|
2415
Aveanna Healthcare
AVAH
$1.67B
| $434K | ﹤0.01% | +95,000 | New | +$434K |
|
2416
Definitive Healthcare
DH
$419M
| $425K | ﹤0.01% | 103,300 | – | – |
|
2417
Greene County Bancorp
GCBC
$408M
| $415K | ﹤0.01% | 14,979 | – | – |
|
2418
Tourmaline Bio
TRML
$601M
| $408K | ﹤0.01% | +20,100 | New | +$408K |
|
2419
Beyond Meat
BYND
$192M
| $400K | ﹤0.01% | 106,500 -14,400 | -12% | -$54.1K |
|
2420
AnaptysBio
ANAB
$569M
| $393K | ﹤0.01% | 29,700 +3,200 | +12% | +$42.4K |
|
2421
Sana Biotechnology
SANA
$777M
| $388K | ﹤0.01% | 237,900 | – | – |
|
2422
Olema Pharmaceuticals
OLMA
$375M
| $385K | ﹤0.01% | 66,000 | – | – |
|
2423
Korro Bio
KRRO
$217M
| $381K | ﹤0.01% | +10,000 | New | +$381K |
|
|
BBBY
2424
Bed Bath & Beyond, Inc.
BBBY
$517M
| $347K | ﹤0.01% | 70,403 -19,497 | -22% | -$96.1K |
|
2425
Genie Energy
GNE
$409M
| $340K | ﹤0.01% | 21,824 -3,576 | -14% | -$55.8K |
|